185 related articles for article (PubMed ID: 38396380)
21. Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
Mattke M; Ohlinger M; Bougatf N; Harrabi S; Wolf R; Seidensaal K; Welzel T; Röder F; Gerum S; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Uhl M; Debus J
Strahlenther Onkol; 2023 Feb; 199(2):160-168. PubMed ID: 36149438
[TBL] [Abstract][Full Text] [Related]
22. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas.
Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
[TBL] [Abstract][Full Text] [Related]
23. An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia.
Ahern V; Adeberg S; Fossati P; Garrett R; Hoppe B; Mahajan A; Orlandi E; Orecchia R; Prokopovich D; Seuntjens J; Thwaites D; Trifiletti D; Tsang R; Tsuji H
Radiother Oncol; 2023 Oct; 187():109816. PubMed ID: 37480996
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis.
Ma N; Ming X; Chen J; Wu KL; Lu J; Jiang G; Mao J
Radiat Oncol; 2023 Dec; 18(1):195. PubMed ID: 38041122
[TBL] [Abstract][Full Text] [Related]
26. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
[TBL] [Abstract][Full Text] [Related]
27. Particle radiotherapy using protons or carbon ions for unresectable locally advanced head and neck cancers with skull base invasion.
Morimoto K; Demizu Y; Hashimoto N; Mima M; Terashima K; Fujii O; Otsuki N; Murakami M; Fuwa N; Nibu K
Jpn J Clin Oncol; 2014 May; 44(5):428-34. PubMed ID: 24620027
[TBL] [Abstract][Full Text] [Related]
28. Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.
Bush DA; Volk M; Smith JC; Reeves ME; Sanghvi S; Slater JD; deVera M
Cancer; 2023 Nov; 129(22):3554-3563. PubMed ID: 37503907
[TBL] [Abstract][Full Text] [Related]
29. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes.
Lu VM; O'Connor KP; Mahajan A; Carlson ML; Van Gompel JJ
J Neurooncol; 2020 May; 147(3):503-513. PubMed ID: 32206977
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis.
Dong M; Wu J; Wu R; Wang D; Liu R; Luo H; Wang Y; Chen J; Ou Y; Zhang Q; Wang X
Radiat Oncol; 2023 Feb; 18(1):31. PubMed ID: 36805784
[TBL] [Abstract][Full Text] [Related]
31. Proton beam therapy for skull base chordomas: a systematic review of tumor control rates and survival rates.
Pahwa B; Medani K; Lu VM; Elarjani T
Neurosurg Rev; 2022 Dec; 45(6):3551-3563. PubMed ID: 36181614
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
[TBL] [Abstract][Full Text] [Related]
33. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy: Organ doses in pediatric brain tumor treatment.
Matsumoto S; Yonai S; Bolch WE
Med Phys; 2019 Dec; 46(12):5824-5832. PubMed ID: 31603561
[TBL] [Abstract][Full Text] [Related]
34. Repeated Carbon-Ion Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
Tomizawa K; Shibuya K; Shiba S; Okazaki S; Miyasaka Y; Oishi M; Okamoto M; Ohno T
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1100-1109. PubMed ID: 36870514
[TBL] [Abstract][Full Text] [Related]
35. Carbon Ion Radiotherapy for sacral chordoma: a systematic review of the literature.
Evangelisti G; Sartini F; Bandiera S; Barbanti Brodano G; Griffoni C; Girolami M; Pipola V; Gasbarrini A
J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 3):353-361. Congress of the Italian Orthopaedic Research Society. PubMed ID: 33261300
[TBL] [Abstract][Full Text] [Related]
36. Salvage Carbon Ion Radiation Therapy for Locally Recurrent or Radiation-Induced Second Primary Sarcoma of the Head and Neck.
Yang J; Gao J; Wu X; Hu J; Hu W; Kong L; Lu JJ
J Cancer; 2018; 9(12):2215-2223. PubMed ID: 29937942
[No Abstract] [Full Text] [Related]
37. Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity.
Ronchi S; Cicchetti A; Bonora M; Ingargiola R; Camarda AM; Russo S; Imparato S; Castelnuovo P; Pasquini E; Nicolai P; Ansarin M; Del Vecchio M; Benazzo M; Orlandi E; Vischioni B
Radiother Oncol; 2024 Jan; 190():110003. PubMed ID: 37956889
[TBL] [Abstract][Full Text] [Related]
38. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
39. Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.
Xi M; Xu C; Liao Z; Chang JY; Gomez DR; Jeter M; Cox JD; Komaki R; Mehran R; Blum MA; Hofstetter WL; Maru DM; Bhutani MS; Lee JH; Weston B; Ajani JA; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):667-676. PubMed ID: 29280461
[TBL] [Abstract][Full Text] [Related]
40. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
Iijima M; Okonogi N; Nakajima NI; Morokoshi Y; Kanda H; Yamada T; Kobayashi Y; Banno K; Wakatsuki M; Yamada S; Kamada T; Aoki D; Hasegawa S
J Gynecol Oncol; 2020 Mar; 31(2):e19. PubMed ID: 31912675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
